Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 213

1.

Disruption of VEGF Mediated Flk-1 Signaling Leads to a Gradual Loss of Vessel Health and Cardiac Function During Myocardial Infarction: Potential Therapy With Pellino-1.

Thirunavukkarasu M, Selvaraju V, Joshi M, Coca-Soliz V, Tapias L, Saad I, Fournier C, Husain A, Campbell J, Yee SP, Sanchez JA, Palesty JA, McFadden DW, Maulik N.

J Am Heart Assoc. 2018 Sep 18;7(18):e007601. doi: 10.1161/JAHA.117.007601.

2.

Graphene-based drug delivery systems in tissue engineering and nanomedicine.

Lakshmanan R, Maulik N.

Can J Physiol Pharmacol. 2018 Sep;96(9):869-878. doi: 10.1139/cjpp-2018-0225. Epub 2018 Aug 23. Review.

PMID:
30136862
3.

Thioredoxin-1 augments wound healing and promote angiogenesis in a murine ischemic full-thickness wound model.

Saad I, Fournier CT, Wilson RL, Lakshmanan R, Selvaraju V, Thirunavukkarasu M, Alexander Palesty J, McFadden DW, Maulik N.

Surgery. 2018 Nov;164(5):1077-1086. doi: 10.1016/j.surg.2018.05.045. Epub 2018 Aug 18.

PMID:
30131176
4.

Thioredoxin-1 attenuates sepsis-induced cardiomyopathy after cecal ligation and puncture in mice.

Wilson RL, Selvaraju V, Lakshmanan R, Thirunavukkarasu M, Campbell J, McFadden DW, Maulik N.

J Surg Res. 2017 Dec;220:68-78. doi: 10.1016/j.jss.2017.06.062. Epub 2017 Jul 25.

PMID:
29180214
5.

Development of next generation cardiovascular therapeutics through bio-assisted nanotechnology.

Lakshmanan R, Maulik N.

J Biomed Mater Res B Appl Biomater. 2018 Jul;106(5):2072-2083. doi: 10.1002/jbm.b.34000. Epub 2017 Sep 26. Review.

PMID:
28950048
6.

Overexpression of Thioredoxin1 enhances functional recovery in a mouse model of hind limb ischemia.

Shaikh IA, Rishi MT, Youssef M, Selvaraju V, Thirunavukkarasu M, Ukani G, Lakshmanan R, Palesty JA, Maulik N.

J Surg Res. 2017 Aug;216:158-168. doi: 10.1016/j.jss.2017.04.019. Epub 2017 May 5.

PMID:
28807201
7.

Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.

Lakshmanan R, Ukani G, Rishi MT, Maulik N.

Can J Physiol Pharmacol. 2017 Oct;95(10):1125-1140. doi: 10.1139/cjpp-2016-0713. Epub 2017 Apr 13. Review.

PMID:
28407473
8.

Regulation of A-Kinase-Anchoring Protein 12 by Heat Shock Protein A12B to Prevent Ventricular Dysfunction Following Acute Myocardial Infarction in Diabetic Rats.

Selvaraju V, Suresh SC, Thirunavukkarasu M, Mannu J, Foye JLC, Mathur PP, Palesty JA, Sanchez JA, McFadden DW, Maulik N.

J Cardiovasc Transl Res. 2017 Apr;10(2):209-220. doi: 10.1007/s12265-017-9734-4. Epub 2017 Mar 9.

PMID:
28281242
9.

Increased survivability of ischemic skin flap tissue in Flk-1+/- mice by Pellino-1 intervention.

Rednam CK, Wilson RL, Selvaraju V, Rishi MT, Thirunavukkarasu M, Coca-Soliz V, Lakshmanan R, Palesty JA, McFadden DW, Maulik N.

Microcirculation. 2017 Aug;24(6). doi: 10.1111/micc.12362.

PMID:
28177171
10.

Reply to the letter "thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction".

Maulik N, Thirunavukkarasu M, Selvaraju V, Suresh SC.

Int J Cardiol. 2016 Mar 15;207:277-8. doi: 10.1016/j.ijcard.2016.01.047. Epub 2016 Jan 6. No abstract available.

PMID:
26808992
11.

Thioredoxins in cardiovascular disease.

Whayne TF Jr, Parinandi N, Maulik N.

Can J Physiol Pharmacol. 2015 Nov;93(11):903-11. doi: 10.1139/cjpp-2015-0105. Epub 2015 May 21. Review.

PMID:
26417924
12.

Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: the role of PI3-kinase/glycogen synthase kinase 3β/β-catenin pathway.

Thirunavukkarasu M, Selvaraju V, Tapias L, Sanchez JA, Palesty JA, Maulik N.

J Physiol Biochem. 2015 Dec;71(4):623-33. doi: 10.1007/s13105-015-0426-8. Epub 2015 Sep 5.

PMID:
26342597
13.

Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.

Suresh SC, Selvaraju V, Thirunavukkarasu M, Goldman JW, Husain A, Alexander Palesty J, Sanchez JA, McFadden DW, Maulik N.

Int J Cardiol. 2015 Dec 15;201:517-28. doi: 10.1016/j.ijcard.2015.08.117. Epub 2015 Aug 15.

PMID:
26322599
14.

Antioxidants in Longevity and Medicine 2014.

Parinandi NL, Maulik N, Thirunavukkarasu M, McFadden DW.

Oxid Med Cell Longev. 2015;2015:739417. doi: 10.1155/2015/739417. Epub 2015 May 11. No abstract available.

15.

Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-α Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1α and Mitochondrial Homeostasis.

Wang Y, Cao Y, Yamada S, Thirunavukkarasu M, Nin V, Joshi M, Rishi MT, Bhattacharya S, Camacho-Pereira J, Sharma AK, Shameer K, Kocher JP, Sanchez JA, Wang E, Hoeppner LH, Dutta SK, Leof EB, Shah V, Claffey KP, Chini EN, Simons M, Terzic A, Maulik N, Mukhopadhyay D.

Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1401-12. doi: 10.1161/ATVBAHA.115.305566. Epub 2015 Apr 16.

16.

Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia.

Rishi MT, Selvaraju V, Thirunavukkarasu M, Shaikh IA, Takeda K, Fong GH, Palesty JA, Sanchez JA, Maulik N.

Microvasc Res. 2015 Jan;97:181-8. doi: 10.1016/j.mvr.2014.10.009. Epub 2014 Nov 3.

PMID:
25446011
17.

Antioxidants in longevity and medicine.

Maulik N, McFadden D, Otani H, Thirunavukkarasu M, Parinandi NL.

Oxid Med Cell Longev. 2013;2013:820679. doi: 10.1155/2013/820679. Epub 2013 Nov 12. No abstract available.

18.

Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.

Joshi M, Kotha SR, Malireddy S, Selvaraju V, Satoskar AR, Palesty A, McFadden DW, Parinandi NL, Maulik N.

Mol Cell Biochem. 2014 Jan;386(1-2):233-49. doi: 10.1007/s11010-013-1861-x. Epub 2013 Dec 4. Review.

PMID:
24307101
19.

Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Selvaraju V, Parinandi NL, Adluri RS, Goldman JW, Hussain N, Sanchez JA, Maulik N.

Antioxid Redox Signal. 2014 Jun 1;20(16):2631-65. doi: 10.1089/ars.2013.5186. Epub 2013 Oct 31. Review.

20.

Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction.

Oriowo B, Thirunavukkarasu M, Selvaraju V, Adluri RS, Zhan L, Takeda K, Fong GH, Sanchez JA, Maulik N.

Curr Pharm Des. 2014;20(9):1305-10.

PMID:
23978105

Supplemental Content

Loading ...
Support Center